Jeffrey W. Albers, Director at Blueprint Medicines Corp (BPMC), sold 10,000 shares at $79.07 ($791K) on 2023-12-11, disclosed to the SEC on 2023-12-13.
Scheduled sale ($791k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.07 | 5,000 | $395K | 50.0% |
| 2 | $79.07 | 5,000 | $395K | 50.0% |
| Total | $79.07 avg | 10,000 | $791K | 100% |
| Filing → |
| KYMR | SELL | 2025-10-14 | $296K | — | Filing → |
| KYMR | SELL | 2025-06-03 | $311K | — | Filing → |
| BPMC | SELL | 2025-05-29 | $572K | — | Filing → |